Who owns Benitec Biopharma Inc.?
Institutional ownership of BNTC from SEC Form 13F filings across 68 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
68
13F holders
$352.6M
value, 2026 filers
76.8%
of shares outstanding (26.4M sh)
11
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of BNTC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 11.5M | $154.5M | 2.8% | 33.6% | 0.0% |
| 2 | Jupiter Topco LLCNEW | 2.5M | $33.1M | 0.0% | 7.2% | new |
| 3 | FRANKLIN RESOURCES INC | 2.4M | $32.3M | 0.0% | 7% | +1.5% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.1M | $28.4M | 0.0% | 6.2% | 0.0% |
| 5 | BlackRock, Inc. | 1.4M | $18.8M | 0.0% | 4.1% | +18.7% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 954,533 | $12.8M | 0.0% | 2.8% | -48.8% |
| 7 | MILLENNIUM MANAGEMENT LLC | 921,299 | $12.3M | 0.0% | 2.7% | +41.3% |
| 8 | SILVERARC CAPITAL MANAGEMENT, LLC | 679,826 | $9.1M | 0.9% | 2% | -5.3% |
| 9 | Balyasny Asset Management L.P. | 650,503 | $8.7M | 0.0% | 1.9% | -0.5% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 611,736 | $8.2M | 0.0% | 1.8% | +16.7% |
| 11 | AMERIPRISE FINANCIAL INC | 401,245 | $5.4M | 0.0% | 1.2% | +26.0% |
| 12 | MYDA Advisors LLC | 250,000 | $3.3M | 0.5% | 0.7% | +11.1% |
| 13 | Schonfeld Strategic Advisors LLC | 235,357 | $3.1M | 0.0% | 0.7% | +53.6% |
| 14 | NORTHERN TRUST CORP | 178,434 | $2.4M | 0.0% | 0.5% | +13.4% |
| 15 | GOLDMAN SACHS GROUP INC | 178,041 | $2.4M | 0.0% | 0.5% | -17.4% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 160,995 | $2.2M | 0.0% | 0.5% | -6.3% |
| 17 | Burkehill Global Management, LP | 150,000 | $2.0M | 0.1% | 0.4% | 0.0% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 143,510 | $1.9M | 0.0% | 0.4% | +25.1% |
| 19 | Russell Investments Group, Ltd. | 128,970 | $1.7M | 0.0% | 0.4% | +11.0% |
| 20 | UBS Group AG | 125,431 | $1.7M | 0.0% | 0.4% | +8.3% |
| 21 | CITADEL ADVISORS LLC | 81,466 | $1.1M | 0.0% | 0.2% | -52.6% |
| 22 | Sixth Street Partners Management Company, L.P.NEW | 70,851 | $947,986 | 0.2% | 0.2% | new |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 70,851 | $947,986 | 0.0% | 0.2% | +15.4% |
| 24 | Bank of New York Mellon Corp | 60,061 | $803,616 | 0.0% | 0.2% | +38.1% |
| 25 | CANTOR FITZGERALD, L. P. | 46,659 | $624,297 | 0.0% | 0.1% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.